Inventor

Henry J. Breslin

Inventor
Lansdale, PA, US

Overview

37→
Patents
1993–2019
Patent span
Chemistry
Primary field (CPC C)

Patents· 37 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary
C07DHeterocyclic compounds39%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations31%
A61KPreparations for medical, dental or toiletry purposes18%
C07CAcyclic or carbocyclic compounds11%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium2%
PatentTitleYear
10,301,324Ataxia telengiectasia and rad3-related (ATR) inhibitors and methods of their use201910,213,415Compounds as opioid receptor modulators201910,196,405Ataxia telengiectasia and Rad3-related (ATR) protein kinase inhibitors20199,981,989Ataxia telengiectasia and Rad3-related (ATR) protein kinase inhibitors20189,914,730'Azaquinazoline inhibitors of Atypical protein Kinase C'20189,896,446'Azaquinazoline inhibitors of atypical protein kinase C'20189,700,542'Compounds as opioid receptor modulators'20179,663,535'Ataxia telengiectasia and Rad3-related (ATR) protein kinase inhibitors'20179,487,529'Macrocyclic compounds as ALK, FAK and JAK2 inhibitors'20169,238,656'Imidazo[4,5-b]pyridine derivatives as ALK and JAK modulators for the treatment of proliferative disorders'20169,205,076'Compounds as opioid receptor modulators'20158,895,573'Phenoxy-substituted pyrimidines as opioid receptor modulators'20148,772,325'Compounds as opioid receptor modulators'20148,609,709'Compounds as opioid receptor modulators'20138,552,186'Fused bicyclic derivatives of 2,4-diaminopyrimidine as ALK and c-MET inhibitors'20138,471,005'Pyrrolotriazines as ALK and JAK2 inhibitors'20138,394,809'Phenoxy-substituted pyrimidines as opioid receptor modulators'20138,344,011'Compounds as opioid receptor modulators'20138,247,432'Tripeptidyl peptidase inhibitors'20128,148,391'Fused bicyclic derivatives of 2,4-diaminopyrimidine as ALK and c-Met inhibitors'20127,947,713'Tripeptidyl peptidase inhibitors'20117,943,635'Benzylimidazolyl substituted 2-quinoline and quinazoline derivatives for use as farnesyl transferase inhibitors'20117,786,158'Compounds as opioid receptor modulators'20107,741,356'Compounds as opioid receptor modulators'20107,659,402'Piperidines as opioid receptor modulators'20107,592,356'Triazoles as farnesyl transferase inhibitors'20097,511,061'Triazoles as farnesyl transferase inhibitors'20097,241,777'Benzylimidazolyl substituted 2-quinoline and quinazoline derivatives for use as farnesyl transferase inhibitors'20077,202,381'Compounds as opioid receptor modulators'20077,125,891'Tripeptidyl peptidase inhibitors'20067,049,324'Triazoles as farnesyl transferase inhibitors'20067,041,681'Compounds as opioid receptor modulators'20066,201,119'Antiretroviral tetrahydroimidazo[1,4]benzodiazepin-2(thi) ones'20015,371,079'Antiretroviral tetrahydroimidazo[1,4]benzodiazepin-2-(thi)ones'19945,294,708'Guanidine derivatives'19945,270,464'Anti-HIV-1 tetrahydroimidazo[1,4]benzodiazepin-2-(thi) ones'19935,268,373'Guanidine derivatives, compositions and use'1993

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1993–2019Patents assigned to JANSSEN PHARMACEUTICA NV (23)· patent assignee history
1993–2019Based in Lansdale, PA, US· patent location history
2006–2012Patents assigned to BRESLIN HENRY JOSEPH (3)· patent assignee history
2012–2016Patents assigned to CEPHALON INC (5)· patent assignee history
2013Patents assigned to BRESLIN HENRY J (3)· patent assignee history
2017–2019Patents assigned to Atrin Pharmaceuticals LLC (4)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
JANSSEN PHARMACEUTICA NV231993–2019
CEPHALON INC52012–2016
Atrin Pharmaceuticals LLC42017–2019
BRESLIN HENRY Jself32013
BRESLIN HENRY JOSEPHself32006–2012
Locations
LocationPatentsSpan
Lansdale, Pennsylvania, US371993–2019